Biomarkers in the Health and Depression Disorder
Biomarkers are used in all health fields to aid in the
diagnosis of illnesses. By definition, biomarkers are a measurable substance
that is an indicator of a distinct disease, infection, or environmental
exposure. Biomarkers include ions,
genetic markers, proteins, and structural abnormalities. Mental health
scientists are currently working on many different biomarkers in order to help
define, identify, and effectively treat mental illnesses. A biomarker in mental
health is blood testing and urine sampling, which is now being used to detect
disorders such as Alzheimer’s disease and Major Depressive Disorder.
The next most common form of depression is Low-Folate
depression folate is one of the B-vitamins. Folaters’ primary job is to convert
B12 Vitamin into a different form so it can be used in DNA synthesis. Foliate
is also involved in cell growth. There is a specific form of folate that has
access to the brain. This specific kind of Folate, known as Methylfolate, and
it is involved in the synthesis of Serotonin as well as other
neurotransmitters. By administering this Folate to individuals suffering
from depression, it will create more Serotonin in the brain and ultimately aid
in alleviating symptoms.
Biomarkers of treatment response may enable clinicians to
target the appropriate drug for each patient. Biomarkers need to have accuracy
in real life, sensitivity, specificity, and relevance to depression.
Introduction of Depressive Disorder biomarkers into the health care system can
increase the overall cost of clinical diagnosis of patients. Because of that,
decisions to allocate health research funding must be based on drug
effectiveness and cost-effectiveness. The assessment of Depressive Disorder
biomarkers should include reliable evidence of associated drug effectiveness, adverse
events and consequences. To
have the discussions about the Biomarkers in the health and depression
disorder of Clinical
Research and Biomarkers (WCCRB-2018) this is during September
17-18, 2018 at Toronto, Canada
0 comments: